Eintrag weiter verarbeiten

Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients

Gespeichert in:

Veröffentlicht in: PLOS ONE 11(2016,8) Artikel-Nummer e0161012, 16 Seiten
Personen und Körperschaften: Dietz, Steffen (VerfasserIn), Schirmer, Uwe (VerfasserIn), Mercé, Clémentine (VerfasserIn), Meister, Michael (VerfasserIn), Muley, Thomas (VerfasserIn), Thomas, Michael (VerfasserIn), Sültmann, Holger (VerfasserIn)
Titel: Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients/ Steffen Dietz, Uwe Schirmer, Clémentine Mercé, Nikolas von Bubnoff, Edgar Dahl, Michael Meister, Thomas Muley, Michael Thomas, Holger Sültmann
Format: E-Book-Kapitel
Sprache: Englisch
veröffentlicht:
16 August 2016
Gesamtaufnahme: : PLOS ONE, 11(2016,8) Artikel-Nummer e0161012, 16 Seiten
, volume:11
Schlagwörter:
Quelle: Verbunddaten SWB
Lizenzfreie Online-Ressourcen
LEADER 04771caa a2200697 4500
001 0-1571284575
003 DE-627
005 20230814093900.0
007 cr uuu---uuuuu
008 180321s2016 xx |||||o 00| ||eng c
024 7 |a 10.1371/journal.pone.0161012  |2 doi 
035 |a (DE-627)1571284575 
035 |a (DE-576)501284575 
035 |a (DE-599)BSZ501284575 
035 |a (OCoLC)1340994768 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
100 1 |a Dietz, Steffen  |d 1988-  |e VerfasserIn  |0 (DE-588)1148996575  |0 (DE-627)1009298062  |0 (DE-576)496511556  |4 aut 
245 1 0 |a Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients  |c Steffen Dietz, Uwe Schirmer, Clémentine Mercé, Nikolas von Bubnoff, Edgar Dahl, Michael Meister, Thomas Muley, Michael Thomas, Holger Sültmann 
264 1 |c 16 August 2016 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 21.03.2018 
520 |a Circulating cell-free DNA (cfDNA) released from cancerous tissues has been found to harbor tumor-associated alterations and to represent the molecular composition of the tumor. Recent advances in technologies, especially in next-generation sequencing, enable the analysis of low amounts of cfDNA from body fluids. We analyzed the exomes of tumor tissue and matched serum samples to investigate the molecular representation of the tumor exome in cfDNA. To this end, we implemented a workflow for sequencing of cfDNA from low serum volumes (200 μl) and performed whole-exome sequencing (WES) of serum and matched tumor tissue samples from six non-small cell lung cancer (NSCLC) patients and two control sera. Exomes, including untranslated regions (UTRs) of cfDNA were sequenced with an average coverage of 68.5x. Enrichment efficiency, target coverage, and sequencing depth of cfDNA reads were comparable to those from matched tissues. Discovered variants were compared between serum and tissue as well as to the COSMIC database of known mutations. Although not all tissue variants could be confirmed in the matched serum, up to 57% of the tumor variants were reflected in matched cfDNA with mutations in PIK3CA, ALK, and PTEN as well as variants at COSMIC annotated sites in all six patients analyzed. Moreover, cfDNA revealed a mutation in MTOR, which was not detected in the matched tissue, potentially from an untested region of the heterogeneous primary tumor or from a distant metastatic clone. WES of cfDNA may provide additional complementary molecular information about clinically relevant mutations and the clonal heterogeneity of the tumors. 
650 4 |a DNA libraries 
650 4 |a DNA sequencing 
650 4 |a Genomic libraries 
650 4 |a Mutation databases 
650 4 |a Non-small cell lung cancer 
650 4 |a Polymerase chain reaction 
650 4 |a Somatic mutation 
650 4 |a Squamous cell lung carcinoma 
700 1 |a Schirmer, Uwe  |d 1967-  |e VerfasserIn  |0 (DE-588)123258995  |0 (DE-627)706230868  |0 (DE-576)293625816  |4 aut 
700 1 |a Mercé, Clémentine  |e VerfasserIn  |0 (DE-588)1098446852  |0 (DE-627)857632833  |0 (DE-576)469125101  |4 aut 
700 1 |a Meister, Michael  |e VerfasserIn  |0 (DE-588)1078792046  |0 (DE-627)839461402  |0 (DE-576)451890108  |4 aut 
700 1 |a Muley, Thomas  |e VerfasserIn  |0 (DE-588)1056885432  |0 (DE-627)794179169  |0 (DE-576)16759284X  |4 aut 
700 1 |a Thomas, Michael  |e VerfasserIn  |0 (DE-588)1054438781  |0 (DE-627)79152213X  |0 (DE-576)41027089X  |4 aut 
700 1 |a Sültmann, Holger  |d 1962-  |e VerfasserIn  |0 (DE-588)172777291  |0 (DE-627)697708144  |0 (DE-576)133633926  |4 aut 
773 0 8 |i Enthalten in  |t PLOS ONE  |d San Francisco, California, US : PLOS, 2006  |g 11(2016,8) Artikel-Nummer e0161012, 16 Seiten  |h Online-Ressource  |w (DE-627)523574592  |w (DE-600)2267670-3  |w (DE-576)281331979  |x 1932-6203  |7 nnns 
773 1 8 |g volume:11  |g year:2016  |g number:8 
856 4 0 |u http://dx.doi.org/10.1371/journal.pone.0161012  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0161012  |x Verlag  |z kostenfrei  |3 Volltext 
936 u w |d 11  |j 2016  |e 8  |y 11(2016,8) Artikel-Nummer e0161012, 16 Seiten 
951 |a AR 
856 4 0 |u http://dx.doi.org/10.1371/journal.pone.0161012  |9 LFER 
852 |a LFER  |z 2018-04-10T00:00:00Z 
970 |c OD 
971 |c EBOOK 
972 |c EBOOK 
973 |c Aufsatz 
935 |a lfer 
900 |a Muley, Thomas R. 
900 |a Muley, T. 
900 |a Muley, Tomas 
900 |a Dietz, S. 
900 |a Thomas, M. 
900 |a Merce, Clemetine 
900 |a Meister, M. 
951 |b XA-DE 
980 |a 1571284575  |b 0  |k 1571284575  |o 501284575  |c lfer 
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Low+input+whole-exome+sequencing+to+determine+the+representation+of+the+tumor+exome+in+circulating+DNA+of+non-small+cell+lung+cancer+patients&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=Dietz%2C+Steffen&rft.pub=&rft.format=Journal&rft.language=English&rft.issn=1932-6203
SOLR
_version_ 1778848421968347136
access_facet Electronic Resources
author Dietz, Steffen, Schirmer, Uwe, Mercé, Clémentine, Meister, Michael, Muley, Thomas, Thomas, Michael, Sültmann, Holger
author_facet Dietz, Steffen, Schirmer, Uwe, Mercé, Clémentine, Meister, Michael, Muley, Thomas, Thomas, Michael, Sültmann, Holger
author_role aut, aut, aut, aut, aut, aut, aut
author_sort Dietz, Steffen 1988-
author_variant s d sd, u s us, c m cm, m m mm, t m tm, m t mt, h s hs
callnumber-sort
collection lfer
container_reference 11(2016,8) Artikel-Nummer e0161012, 16 Seiten
container_title PLOS ONE
contents Circulating cell-free DNA (cfDNA) released from cancerous tissues has been found to harbor tumor-associated alterations and to represent the molecular composition of the tumor. Recent advances in technologies, especially in next-generation sequencing, enable the analysis of low amounts of cfDNA from body fluids. We analyzed the exomes of tumor tissue and matched serum samples to investigate the molecular representation of the tumor exome in cfDNA. To this end, we implemented a workflow for sequencing of cfDNA from low serum volumes (200 μl) and performed whole-exome sequencing (WES) of serum and matched tumor tissue samples from six non-small cell lung cancer (NSCLC) patients and two control sera. Exomes, including untranslated regions (UTRs) of cfDNA were sequenced with an average coverage of 68.5x. Enrichment efficiency, target coverage, and sequencing depth of cfDNA reads were comparable to those from matched tissues. Discovered variants were compared between serum and tissue as well as to the COSMIC database of known mutations. Although not all tissue variants could be confirmed in the matched serum, up to 57% of the tumor variants were reflected in matched cfDNA with mutations in PIK3CA, ALK, and PTEN as well as variants at COSMIC annotated sites in all six patients analyzed. Moreover, cfDNA revealed a mutation in MTOR, which was not detected in the matched tissue, potentially from an untested region of the heterogeneous primary tumor or from a distant metastatic clone. WES of cfDNA may provide additional complementary molecular information about clinically relevant mutations and the clonal heterogeneity of the tumors.
ctrlnum (DE-627)1571284575, (DE-576)501284575, (DE-599)BSZ501284575, (OCoLC)1340994768
doi_str_mv 10.1371/journal.pone.0161012
facet_avail Online, Free
finc_class_facet not assigned
finc_id_str 0021033275
footnote Gesehen am 21.03.2018
format ElectronicBookComponentPart
format_access_txtF_mv Article, E-Article
format_de105 Ebook
format_de14 Article, E-Article
format_de15 Article, E-Article
format_del152 Buch
format_detail_txtF_mv text-online-monograph-child
format_dezi4 e-Book
format_finc Article, E-Article
format_legacy ElectronicBookPart
format_strict_txtF_mv E-Article
geogr_code not assigned
geogr_code_person Germany
hierarchy_parent_id 0-523574592
hierarchy_parent_title PLOS ONE
hierarchy_sequence 11(2016,8) Artikel-Nummer e0161012, 16 Seiten
hierarchy_top_id 0-523574592
hierarchy_top_title PLOS ONE
id 0-1571284575
illustrated Not Illustrated
imprint 16 August 2016
imprint_str_mv 16 August 2016
institution DE-D117, DE-105, LFER, DE-Ch1, DE-15, DE-14, DE-Zwi2
is_hierarchy_id 0-1571284575
is_hierarchy_title Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients
isil_str_mv LFER
issn 1932-6203
kxp_id_str 1571284575
language English
last_indexed 2023-10-04T17:54:12.428Z
local_heading_facet_dezwi2 DNA libraries, DNA sequencing, Genomic libraries, Mutation databases, Non-small cell lung cancer, Polymerase chain reaction, Somatic mutation, Squamous cell lung carcinoma
marc024a_ct_mv 10.1371/journal.pone.0161012
match_str dietz2016lowinputwholeexomesequencingtodeterminetherepresentationofthetumorexomeincirculatingdnaofnonsmallcelllungcancerpatients
mega_collection Verbunddaten SWB, Lizenzfreie Online-Ressourcen
misc_de105 EBOOK
multipart_link 281331979
multipart_part (281331979)11(2016,8) Artikel-Nummer e0161012, 16 Seiten
names_id_str_mv (DE-588)1148996575, (DE-627)1009298062, (DE-576)496511556, (DE-588)123258995, (DE-627)706230868, (DE-576)293625816, (DE-588)1098446852, (DE-627)857632833, (DE-576)469125101, (DE-588)1078792046, (DE-627)839461402, (DE-576)451890108, (DE-588)1056885432, (DE-627)794179169, (DE-576)16759284X, (DE-588)1054438781, (DE-627)79152213X, (DE-576)41027089X, (DE-588)172777291, (DE-627)697708144, (DE-576)133633926
oclc_num 1340994768
publishDate 16 August 2016
publishDateSort 2016
publishPlace
publisher
record_format marcfinc
record_id 501284575
recordtype marcfinc
rvk_facet No subject assigned
source_id 0
spelling Dietz, Steffen 1988- VerfasserIn (DE-588)1148996575 (DE-627)1009298062 (DE-576)496511556 aut, Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients Steffen Dietz, Uwe Schirmer, Clémentine Mercé, Nikolas von Bubnoff, Edgar Dahl, Michael Meister, Thomas Muley, Michael Thomas, Holger Sültmann, 16 August 2016, Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, Gesehen am 21.03.2018, Circulating cell-free DNA (cfDNA) released from cancerous tissues has been found to harbor tumor-associated alterations and to represent the molecular composition of the tumor. Recent advances in technologies, especially in next-generation sequencing, enable the analysis of low amounts of cfDNA from body fluids. We analyzed the exomes of tumor tissue and matched serum samples to investigate the molecular representation of the tumor exome in cfDNA. To this end, we implemented a workflow for sequencing of cfDNA from low serum volumes (200 μl) and performed whole-exome sequencing (WES) of serum and matched tumor tissue samples from six non-small cell lung cancer (NSCLC) patients and two control sera. Exomes, including untranslated regions (UTRs) of cfDNA were sequenced with an average coverage of 68.5x. Enrichment efficiency, target coverage, and sequencing depth of cfDNA reads were comparable to those from matched tissues. Discovered variants were compared between serum and tissue as well as to the COSMIC database of known mutations. Although not all tissue variants could be confirmed in the matched serum, up to 57% of the tumor variants were reflected in matched cfDNA with mutations in PIK3CA, ALK, and PTEN as well as variants at COSMIC annotated sites in all six patients analyzed. Moreover, cfDNA revealed a mutation in MTOR, which was not detected in the matched tissue, potentially from an untested region of the heterogeneous primary tumor or from a distant metastatic clone. WES of cfDNA may provide additional complementary molecular information about clinically relevant mutations and the clonal heterogeneity of the tumors., DNA libraries, DNA sequencing, Genomic libraries, Mutation databases, Non-small cell lung cancer, Polymerase chain reaction, Somatic mutation, Squamous cell lung carcinoma, Schirmer, Uwe 1967- VerfasserIn (DE-588)123258995 (DE-627)706230868 (DE-576)293625816 aut, Mercé, Clémentine VerfasserIn (DE-588)1098446852 (DE-627)857632833 (DE-576)469125101 aut, Meister, Michael VerfasserIn (DE-588)1078792046 (DE-627)839461402 (DE-576)451890108 aut, Muley, Thomas VerfasserIn (DE-588)1056885432 (DE-627)794179169 (DE-576)16759284X aut, Thomas, Michael VerfasserIn (DE-588)1054438781 (DE-627)79152213X (DE-576)41027089X aut, Sültmann, Holger 1962- VerfasserIn (DE-588)172777291 (DE-627)697708144 (DE-576)133633926 aut, Enthalten in PLOS ONE San Francisco, California, US : PLOS, 2006 11(2016,8) Artikel-Nummer e0161012, 16 Seiten Online-Ressource (DE-627)523574592 (DE-600)2267670-3 (DE-576)281331979 1932-6203 nnns, volume:11 year:2016 number:8, http://dx.doi.org/10.1371/journal.pone.0161012 Verlag Resolving-System kostenfrei Volltext, http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0161012 Verlag kostenfrei Volltext, http://dx.doi.org/10.1371/journal.pone.0161012 LFER, LFER 2018-04-10T00:00:00Z
spellingShingle Dietz, Steffen, Schirmer, Uwe, Mercé, Clémentine, Meister, Michael, Muley, Thomas, Thomas, Michael, Sültmann, Holger, Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients, Circulating cell-free DNA (cfDNA) released from cancerous tissues has been found to harbor tumor-associated alterations and to represent the molecular composition of the tumor. Recent advances in technologies, especially in next-generation sequencing, enable the analysis of low amounts of cfDNA from body fluids. We analyzed the exomes of tumor tissue and matched serum samples to investigate the molecular representation of the tumor exome in cfDNA. To this end, we implemented a workflow for sequencing of cfDNA from low serum volumes (200 μl) and performed whole-exome sequencing (WES) of serum and matched tumor tissue samples from six non-small cell lung cancer (NSCLC) patients and two control sera. Exomes, including untranslated regions (UTRs) of cfDNA were sequenced with an average coverage of 68.5x. Enrichment efficiency, target coverage, and sequencing depth of cfDNA reads were comparable to those from matched tissues. Discovered variants were compared between serum and tissue as well as to the COSMIC database of known mutations. Although not all tissue variants could be confirmed in the matched serum, up to 57% of the tumor variants were reflected in matched cfDNA with mutations in PIK3CA, ALK, and PTEN as well as variants at COSMIC annotated sites in all six patients analyzed. Moreover, cfDNA revealed a mutation in MTOR, which was not detected in the matched tissue, potentially from an untested region of the heterogeneous primary tumor or from a distant metastatic clone. WES of cfDNA may provide additional complementary molecular information about clinically relevant mutations and the clonal heterogeneity of the tumors., DNA libraries, DNA sequencing, Genomic libraries, Mutation databases, Non-small cell lung cancer, Polymerase chain reaction, Somatic mutation, Squamous cell lung carcinoma
swb_id_str 501284575
title Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients
title_auth Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients
title_full Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients Steffen Dietz, Uwe Schirmer, Clémentine Mercé, Nikolas von Bubnoff, Edgar Dahl, Michael Meister, Thomas Muley, Michael Thomas, Holger Sültmann
title_fullStr Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients Steffen Dietz, Uwe Schirmer, Clémentine Mercé, Nikolas von Bubnoff, Edgar Dahl, Michael Meister, Thomas Muley, Michael Thomas, Holger Sültmann
title_full_unstemmed Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients Steffen Dietz, Uwe Schirmer, Clémentine Mercé, Nikolas von Bubnoff, Edgar Dahl, Michael Meister, Thomas Muley, Michael Thomas, Holger Sültmann
title_in_hierarchy Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients / Steffen Dietz, Uwe Schirmer, Clémentine Mercé, Nikolas von Bubnoff, Edgar Dahl, Michael Meister, Thomas Muley, Michael Thomas, Holger Sültmann,
title_short Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients
title_sort low input whole exome sequencing to determine the representation of the tumor exome in circulating dna of non small cell lung cancer patients
topic DNA libraries, DNA sequencing, Genomic libraries, Mutation databases, Non-small cell lung cancer, Polymerase chain reaction, Somatic mutation, Squamous cell lung carcinoma
topic_facet DNA libraries, DNA sequencing, Genomic libraries, Mutation databases, Non-small cell lung cancer, Polymerase chain reaction, Somatic mutation, Squamous cell lung carcinoma
url http://dx.doi.org/10.1371/journal.pone.0161012, http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0161012